CTLA4 and melanoma: We therefore evaluated six CTLA-4 Single Nucleotide Polymorphisms (SNPs) in a cohort of high-risk melanoma patients enrolled in a study of two regimens of HDI, and compared the distribution of these SNPS to those found in healthy controls (healthy unrelated individuals from the Donor Marrow Registry of the National Tissue Typing Center, Athens, Greece).